Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest cancer detection Stories

2014-04-17 23:02:49

Medical animation and illustration firm promotes health literacy through popular social media channels. Atlanta, GA (PRWEB) April 17, 2014 Nucleus Medical Media offers no-charge informational medical animations in recognition of May 2014 as Skin Cancer Detection and Prevention Month. The U.S. Department of Health and Human Services says, “Skin cancer is the most common type of cancer in the United States. Ultraviolet (UV) radiation from the sun is the main cause of skin cancer. UV...

2014-01-20 12:23:47

LONDON, Jan. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Mammography Equipment Market to 2019 - Growth Driven by Technical Advances in Digital Radiography that Enhance Workflow and Improve Breast Cancer Detection Mammography Equipment Market to 2019 - Growth Driven by Technical Advances in Digital Radiography that Enhance Workflow and Improve Breast Cancer Detection Summary GBI Research's report, "Mammography Equipment Market to 2019 -...

2013-12-06 23:25:33

The Company’s Cancer Detection Device is a Powerful Portable Laboratory in a Desktop Enclosure Beverly Hills, CA (PRWEB) December 06, 2013 Ancon Technologies, a company devoted to finding new ways to beat cancer, recently unveiled a new cancer-screening device to the public, the NBT detector. The company’s latest product aims to bring cancer detection to the next level: it uses Nanoparticle Biomarker Tagging (NBT) technology to identify cancer biomarkers in exhaled air. According to...

2013-12-06 12:25:19

The Company's Cancer Detection Device is a Powerful Portable Laboratory in a Desktop Enclosure BEVERLY HILLS, Calif., Dec. 6, 2013 /PRNewswire-iReach/ -- Ancon Technologies, a company devoted to finding new ways to beat cancer, recently unveiled a new cancer-screening device to the public, the NBT detector. The company's latest product aims to bring cancer detection to the next level: it uses Nanoparticle Biomarker Tagging (NBT) technology to identify cancer biomarkers in exhaled...

2013-12-03 13:38:19

Compared to traditional mammography, 3D mammography—known as digital breast tomosynthesis—found 22 percent more breast cancers and led to fewer call backs in a large screening study at the Hospital of the University of Pennsylvania (HUP), researchers reported today at the annual meeting of the Radiological Society of North America (RSNA). Conventional digital mammography is the most widely-used screening modality for breast cancer, but may yield suspicious findings that turn out not to...

2013-12-03 13:28:59

Researchers have found that digital breast tomosynthesis (DBT) led to reduced recall rates and an increase in cancer detection in a large breast cancer screening program. The results of this study were presented today at the annual meeting of the Radiological Society of North America (RSNA). Digital mammography is the gold standard for breast cancer screening, but may yield suspicious findings that turn out not to be cancer. These false-positive findings are associated with a higher recall...

2013-12-03 00:21:22

CHICAGO, Dec. 3, 2013 /PRNewswire-USNewswire/ -- Researchers have found that digital breast tomosynthesis (DBT) led to reduced recall rates and an increase in cancer detection in a large breast cancer screening program. The results of this study were presented today at the annual meeting of the Radiological Society of North America (RSNA). Digital mammography is the gold standard for breast cancer screening, but may yield suspicious findings that turn out not to be cancer. These...

2013-11-07 23:03:39

Reportbuyer.com just published a new market research report: Molecular Biomarkers for Cancer Detection and Management. London (PRWEB) November 07, 2013 New to Insight Pharma Reports is Molecular Biomarkers for Cancer Detection and Management: Technologies, Markets, and Trends. This report focuses on recent progress and new directions in this highly dynamic diagnostic field. Covering extensive background and history, commercialization, and marketing trends of cancer biomarker technologies,...

2013-10-22 12:28:48

Virginia-based HDL, Inc. will acquire and operate Oncimmune's Kansas lab and become exclusive licensed U.S. provider of EarlyCDT- Lung, world's first autoantibody test for early detection of lung cancer RICHMOND, Va., Oct. 22, 2013 /PRNewswire/ -- Health Diagnostic Laboratory, Inc. has acquired substantially all of the assets of Oncimmune USA, LLC, the subsidiary of Oncimmune Ltd., a United Kingdom-based company that developed, patented and commercialized a simple physician-ordered...

2013-10-22 08:34:30

PHILADELPHIA, Oct. 22, 2013 /PRNewswire/ -- UE LifeSciences Inc. (UELS), medical device maker of innovative breast cancer detection tools, has announced a crowd-funding campaign to help fight breast cancer. The 'We Must Try' campaign will offer 25,000 women painless and radiation-free breast examinations at several clinics in India, Mexico, Panama, Brazil and Egypt. (Photo: http://photos.prnewswire.com/prnh/20131022/PH01810-a ) (Photo:...